NEW YORK, March 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INVO, NCLH, NOVN, ALT, and RIG.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  • INVO: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=INVO&prnumber=031620211
  • NCLH: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=NCLH&prnumber=031620211
  • NOVN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=NOVN&prnumber=031620211
  • ALT: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ALT&prnumber=031620211
  • RIG: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=RIG&prnumber=031620211

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-invo-bioscience-norwegian-cruise-line-novan-altimmune-or-transocean-301246272.html

SOURCE InvestorsObserver